ALB vs ZTS · rev $1.74B vs P/E 25, rev $2.47B
Albemarle Corp (ALB) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
ALB currently screens at market cap $8.00B. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the ALB and ZTS stock pages for the full models.
Not investment advice.